MR inhibition in macrophages has been shown to reduce pro-inflammatory markers and promote an anti-inflammatory (M2) phenotype, which may offer protection against the transition from acute kidney injury to CKD [50,51]. Here, NR3C2 is linked to chronic kidney disease.